Abstract Library

#1786 Targeted Therapies (TT) (Sunitinib and Everolimus) for Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET). A Case Series

Introduction: Sunitinib (Sun) and Everolimus (Eve) are effective treatments for advanced GEP-NET. Lack of standard treatment sequencing and potential toxicities may preclude it´s use.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Pérez de la Puente C

Authors: Pérez de la Puente C, Mando P, Rizzo M, Rivero S, Pesce V,

Keywords: TNE, therapy target,

#1406 Collision Tumor of the Appendix: Mucinous Cystadenoma and Carcinoid. A Case Report

Introduction: Mucinous cystadenoma is the most common of benign neoplasms of the appendix and carcinoid is the most common type of primary malignant lesions of the appendix.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: OConnor J

Authors: Pombo T, O'Connor J, Dominichini E, Belli S, Pesce V,

Keywords: collision tumor, appendix tumor,

#1159 Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract. ARGENTUM Group

Introduction: Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract are rare neoplasms. In the 2000 WHO classification of endocrine tumors, such neoplasms were defined as mixed exocrine-endocrine tumors when each component represents at least 30% of the lesion. In the most recent WHO classification, such neoplasms are called “mixed adenoneuroendocrine carcinomas” (MANECs). They are a challenge for the diagnostic and treatment.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Cabanne A, Bestani C, Pesce V, O'Connor J, Kujaruk M,

Keywords: MANEC, NETs,

#1157 Cardiac Evaluation as Part of the Initial Extension Studies in Neuroendocrine Tumors. Experience in a Multidisciplinary Team. ARGENTUM GROUP

Introduction: Carcinoid heart disease (CHD) is a complication of metastatic neuroendocrine tumors and is screened for using echocardiography. Published case series showed that when cardiological evaluation is done at least 50% of the patients have CHD, and 33% had surgical indication.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: santos_chacon@ciudad.com.ar D

Authors: Santos D, O'Connor J, Pesce V, Bestani C, Belli S,

Keywords: Cardiac heart disease, neuroendocrine tumors,

#1154 Selective Internal Radiation Therapy (SIRT) Radioembolisation with 90 Yttrium in Patients with Unresectable Liver Neuroendocrine Metastases in a Specialized Center. An Initial Report

Introduction: Most patients with neuroendocrine tumors present liver metastases at some point of the clinical course. Liver directed treatment, such as 90 Yttrium is a method of treatment used in patients with non-resectable liver lesions, which is effective in the control of symptoms and tumor growth.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: García Mónaco R

Authors: García Mónaco R, Peralta O, O'Connor J, Pesce V, Bestani C,

Keywords: 90Yttrium, radioembolization, neuroendocrine tumors ,